Clinical Trial Update: Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, cisplatin, and amifostine after surgery in locally advanced bladder cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Amifostine (amifostine)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Chicago | Conditions: Bladder Cancer, Drug/Agent Toxicity by Tissue/Organ | Phase 2 | Status: COMPLETED